Development, out-licensing and launch of the novel TLM-018 ophthalmic drug
A specific ophthalmic drug commercialization theme involving the start of TLM-018 development under an intellectual property license agreement with Rohto Pharmaceutical and the eventual launch of related products.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.